Theravance Biopharma (TBPH) Other Non-Current Assets (2013 - 2026)
Theravance Biopharma's Other Non-Current Assets came in at $25.18 million for Q2 2026, down 2.3% from $25.77 million a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Other Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma's Other Non-Current Assets was $24.88 million, up 102.5% from FY2024.
- Other Non-Current Assets has increased in each of the last seven years, with a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $12.29 million in FY2024 (+52.3%), $8.07 million in FY2023 (+16.9%), $6.9 million in FY2022 (+113.7%) and $3.23 million in FY2021 (+31.7%).
- The five-year range for quarterly Other Non-Current Assets is $3.19 million (Q1 2022) to $25.77 million (Q2 2025).
- Year-over-year, Other Non-Current Assets increased in six of the last eight quarters, with growth averaging 94.5%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q3 2021 (growth of 295.8%), and the weakest in Q1 2024 (a decline of 34.7%).
- Business Quant data shows TBPH's Other Non-Current Assets at $25.3 million (Q1 2026), $24.88 million (Q4 2025) and $25.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 25.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.18 Mn |
| Mar 31, 2026 | 25.30 Mn |
| Dec 31, 2025 | 24.88 Mn |
| Sep 30, 2025 | 25.19 Mn |
| Jun 30, 2025 | 25.77 Mn |
| Mar 31, 2025 | 13.82 Mn |
| Dec 31, 2024 | 12.29 Mn |
| Sep 30, 2024 | 7.47 Mn |
| Jun 30, 2024 | 7.73 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Dec 31, 2023 | 8.07 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 11.59 Mn |
| Mar 31, 2023 | 12.09 Mn |
| Dec 31, 2022 | 6.90 Mn |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 3.19 Mn |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.30 Mn |
API Access
Theravance Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();